RGD Reference Report - Molecular changes induced in rat liver by hemorrhage and effects of melanocortin treatment. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Molecular changes induced in rat liver by hemorrhage and effects of melanocortin treatment.

Authors: Lonati, C  Sordi, A  Giuliani, D  Spaccapelo, L  Leonardi, P  Carlin, A  Ottani, A  Galantucci, M  Grieco, P  Catania, A  Guarini, S 
Citation: Lonati C, etal., Anesthesiology. 2012 Mar;116(3):692-700. doi: 10.1097/ALN.0b013e318246ea68.
RGD ID: 7257601
Pubmed: PMID:22266570   (View Abstract at PubMed)
DOI: DOI:10.1097/ALN.0b013e318246ea68   (Journal Full-text)

BACKGROUND: Melanocortin peptides improve hemodynamic parameters and prevent death during severe hemorrhagic shock. In the present research we determined influences of a synthetic melanocortin 1/4 receptor agonist on the molecular changes that occur in rat liver during hemorrhage. METHODS: Controlled-volume hemorrhage was performed in adult rats under general anesthesia by a stepwise blood withdrawal until mean arterial pressure fell to 40 mmHg. Then rats received either saline or the synthetic melanocortin 1/4 receptor agonist Butir-His-D-Phe-Arg-Trp-Sar-NH2 (Ro27-3225; n = 6-8 per group). Hemogasanalysis was performed throughout a 60-min period. Gene expression in liver samples was determined at 1 or 3 h using quantitative real-time polymerase chain reaction. RESULTS: At 1 h, in saline-treated shocked rats, there were significant increases in activating transcription factor 3 (Atf3), early growth response 1 (Egr1), heme oxygenase (decycling) 1 (Hmox1), FBJ murine osteosarcoma viral oncogene homolog (Fos), and jun oncogene (Jun). These changes were prevented by Ro27-3225 (mean +/- SEM: Atf3 152.83 +/- 58.62 vs. 579.00 +/- 124.13, P = 0.002; Egr1 13.21 +/- 1.28 vs. 26.63 +/- 1.02, P = 0.001; Hmox1 3.28 +/- 0.31 vs. 166.54 +/- 35.03, P = 0.002; Fos 4.36 +/- 1.03 vs. 14.90 +/- 3.44, P < 0.001; Jun 6.62 +/- 1.93 vs. 15.07 +/- 2.09, P = 0.005; respectively). Increases in alpha-2-macroglobulin (A2m), heat shock 70kD protein 1A (Hspa1a), erythropoietin (Epo), and interleukin-6 (Il6) occurred at 3 h in shocked rats and were prevented by Ro27-3225 treatment (A2m 6.90 +/- 0.82 vs. 36.73 +/- 4.00, P < 0.001; Hspa1a 10.34 +/- 3.28 vs. 25.72 +/- 3.64, P = 0.001; Epo 0.49 +/- 0.13 vs. 2.37 +/- 0.73, P = 0.002; Il6 1.05 +/- 0.15 vs. 1.88 +/- 0.23, P < 0.001; respectively). Further, at 3 h in shocked rats treated with Ro27-3225 there were significant increases in tight junction protein 1 (Tjp1; 27.30 +/- 2.43 vs. 5.03 +/- 1.68, P < 0.001) and nuclear receptor subfamily 4, group A, member 1 (Nr4a1; 91.03 +/- 16.20 vs. 30.43 +/- 11.0, P = 0.01) relative to sham animals. Treatment with Ro27-3225 rapidly restored blood pressure, hemogasanalysis parameters, and lactate blood levels. CONCLUSIONS: Melanocortin treatment significantly prevents most of the systemic and hepatic detrimental changes induced by hemorrhage.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Hemorrhagic Shock  ISOHspa1a (Rattus norvegicus)7257601; 7257601mRNA:increased expression:liverRGD 
Hemorrhagic Shock  IEP 7257601mRNA:increased expression:liverRGD 

Objects Annotated

Genes (Rattus norvegicus)
Hspa1a  (heat shock protein family A (Hsp70) member 1A)

Genes (Mus musculus)
Hspa1a  (heat shock protein 1A)

Genes (Homo sapiens)
HSPA1A  (heat shock protein family A (Hsp70) member 1A)


Additional Information